dc.creatorAnhê, Gabriel Forato
dc.creatorOkamoto, Maristela Mitiko
dc.creatorKinote, Andrezza
dc.creatorSollon, Carolina
dc.creatorSantos, Camilo de Lellis
dc.creatorAnhe, Fernando F.
dc.creatorLima, Guilherme A.
dc.creatorHirabara, Sandro Massao
dc.creatorVelloso, Lício Augusto
dc.creatorSilva, Silvana Auxiliadora Bordin da
dc.creatorMachado, Ubiratan Fabres
dc.date.accessioned2013-11-07T09:44:00Z
dc.date.accessioned2018-07-04T16:21:59Z
dc.date.available2013-11-07T09:44:00Z
dc.date.available2018-07-04T16:21:59Z
dc.date.created2013-11-07T09:44:00Z
dc.date.issued2012
dc.identifierEUROPEAN JOURNAL OF PHARMACOLOGY, AMSTERDAM, v. 689, n. 41334, supl. 1, Part 6, pp. 285-293, AUG 15, 2012
dc.identifier0014-2999
dc.identifierhttp://www.producao.usp.br/handle/BDPI/42754
dc.identifier10.1016/j.ejphar.2012.06.007
dc.identifierhttp://dx.doi.org/10.1016/j.ejphar.2012.06.007
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1634890
dc.description.abstractQuercetin is a potent anti-inflammatory flavonoid, but its capacity to modulate insulin sensitivity in obese insulin resistant conditions is unknown. This study investigated the effect of quercetin treatment upon insulin sensitivity of ob/ob mice and its potential molecular mechanisms. Obese ob/ob mice were treated with quercetin for 10 weeks, and L6 myotubes were treated with either palmitate or tumor necrosis factor-alpha (TNF alpha) plus quercetin. Cells and muscles were processed for analysis of glucose transporter 4 (GLUT4), TNF alpha and inducible nitric oxide synthase (iNOS) expression, and c-Jun N-terminal kinase (JNK) and inhibitor of nuclear factor-kappa B (NF-kappa B) kinase (I kappa K) phosphorylation. Myotubes were assayed for glucose uptake and NF-kappa B translocation. Chromatin immunoprecipitation assessed NF-kappa B binding to GLUT4 promoter. Quercetin treatment improved whole body insulin sensitivity by increasing GLUT4 expression and decreasing JNK phosphorylation, and TNF alpha and iNOS expression in skeletal muscle. Quercetin suppressed palmitate-induced upregulation of TNF alpha and iNOS and restored normal levels of GLUT4 in myotubes. In parallel, quercetin suppressed TNF alpha-induced reduction of glucose uptake in myotubes. Nuclear accumulation of NF-kappa B in myotubes and binding of NF-kappa B to GLUT4 promoter in muscles of ob/ob mice were also reduced by quercetin. We demonstrated that quercetin decreased the inflammatory status in skeletal muscle of obese mice and in L6 myotubes. This effect was followed by increased muscle GLUT4, with parallel improvement of insulin sensitivity. These results point out quercetin as a putative strategy to manage inflammatory-related insulin resistance. (C) 2012 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherELSEVIER SCIENCE BV
dc.publisherAMSTERDAM
dc.relationEUROPEAN JOURNAL OF PHARMACOLOGY
dc.rightsCopyright ELSEVIER SCIENCE BV
dc.rightsclosedAccess
dc.subjectFLAVONOIDS
dc.subjectINSULIN RESISTANCE
dc.subjectPALMITATE
dc.subjectOBESITY
dc.titleQuercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución